TNF and prostate carcinoma: Finally, a finding revealed that fisetin sensitizes the TNF-related apoptosis-inducing ligand-resistant androgen-dependent LNCaP as well as the androgen-independent PC3 and DU145 prostate cancer cells to TNF-related apoptosis-inducing ligand-induced death.